<DOC>
	<DOCNO>NCT02188056</DOCNO>
	<brief_summary>Patients episode VTE ( DVT / PE ) mortality rate 16-21 % 1 year diagnosis . Morbidity associate VTE mark risk recurrence , estimate 30 % estimate 29 % 8 year follow post-thrombotic syndrome . For number patient , risk factor identify ( congenital acquire thrombophilia , cancer , postpartum , surgery , prolonged immobilization , etc.. ) . In 25-50 % case , etiology remain unknown , justify need well-conducted study determine potential risk factor . In addition , expansion treatment option arrival market new direct oral anticoagulant , allow comparative study effectiveness frequency adverse event treatment .</brief_summary>
	<brief_title>Observational Prospectif Monocentric Registry Patients Suffering From VIE</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<criteria>diagnosis venous thromboembolism establish validated test ( venous Doppler ultrasound low limb , pulmonary angiography , lung scan ventilation / perfusion ) , diagnosis venous thromboembolism make within 15 day , previous inclusion register ( outpatient inpatient ) person n't wish participate study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Venous</keyword>
	<keyword>Thromboembolic</keyword>
	<keyword>Pulmonary embolism</keyword>
</DOC>